Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Mckesson Corp (MCK)

Mckesson Corp (MCK)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 54,354,920
  • Shares Outstanding, K 141,793
  • Annual Sales, $ 263,966 M
  • Annual Income, $ 1,114 M
  • 60-Month Beta 0.66
  • Price/Sales 0.20
  • Price/Cash Flow 12.07
  • Price/Book N/A
Trade MCK with:

Options Overview Details

View History
  • Implied Volatility 24.05% ( -1.13%)
  • Historical Volatility 27.85%
  • IV Percentile 11%
  • IV Rank 1.33%
  • IV High 300.84% on 05/12/22
  • IV Low 20.31% on 03/30/22
  • Put/Call Vol Ratio 2.63
  • Today's Volume 1,297
  • Volume Avg (30-Day) 2,962
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 0
  • Open Int (30-Day) 48,265

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate 6.35
  • Number of Estimates 6
  • High Estimate 6.51
  • Low Estimate 6.24
  • Prior Year 6.15
  • Growth Rate Est. (year over year) +3.25%

Price Performance

See More
Period Period Low Period High Performance
1-Month
341.31 +12.31%
on 11/11/22
401.78 -4.59%
on 11/04/22
+0.91 (+0.24%)
since 10/25/22
3-Month
337.18 +13.69%
on 09/15/22
401.78 -4.59%
on 11/04/22
+16.45 (+4.48%)
since 08/25/22
52-Week
215.27 +78.07%
on 12/01/21
401.78 -4.59%
on 11/04/22
+157.32 (+69.60%)
since 11/24/21

Most Recent Stories

More News
QIAGEN's (QGEN) New Monkeypox Test to Aid Faster Identification

QIAGEN's (QGEN) latest multiplex test is expected to strengthen its portfolio and boost its fight against the global monkeypox outbreak.

MCK : 383.34 (+0.68%)
QGEN : 48.97 (+0.14%)
AMN : 122.48 (+0.50%)
SWAV : 264.27 (+0.08%)
Here's Why You Should Retain Stryker (SYK) Stock For Now

Stryker (SYK) continues to benefit from strength in the robotic arm-assisted surgery platform, Mako, and its broad product portfolio. However, pricing pressure weighs on it.

SYK : 232.74 (+1.06%)
MCK : 383.34 (+0.68%)
AMN : 122.48 (+0.50%)
SWAV : 264.27 (+0.08%)
Zacks.com featured highlights include Archer-Daniels-Midland, McKesson, ParkerHannifin, Booz Allen Hamilton and Darden Restaurants

Archer-Daniels-Midland, McKesson, ParkerHannifin, Booz Allen Hamilton and Darden Restaurants are part of the Zacks Screen of the Week article.

PH : 306.03 (-0.10%)
DRI : 148.39 (+0.04%)
ADM : 97.40 (+0.64%)
MCK : 383.34 (+0.68%)
BAH : 108.01 (+1.79%)
Alcon's (ALC) Latest Buyout to Enhance Its Product Portfolio

Alcon's (ALC) ophthalmic pharmaceutical product suite is expected to be significantly boosted by adding new products following the recent acquisition.

MCK : 383.34 (+0.68%)
ALC : 68.32 (+0.49%)
AMN : 122.48 (+0.50%)
SWAV : 264.27 (+0.08%)
Here's Why You Should Retain Cardinal Health (CAH) Stock Now

Cardinal Health (CAH) continues to gain traction from the solid pharmaceutical segment and a diversified product portfolio. However, the cost of products continues to rise.

CAH : 78.95 (+0.65%)
MCK : 383.34 (+0.68%)
AMN : 122.48 (+0.50%)
SWAV : 264.27 (+0.08%)
3 Reasons to Retain QIAGEN (QGEN) Stock in Your Portfolio

Investors continue to be optimistic about QIAGEN (QGEN) on the back of a series of product launches.

MCK : 383.34 (+0.68%)
QGEN : 48.97 (+0.14%)
AMN : 122.48 (+0.50%)
SWAV : 264.27 (+0.08%)
Here's Why You Should Retain Glaukos (GKOS) in Your Portfolio

Glaukos (GKOS) continues to benefit from a robust product portfolio and favorable clinical trial results.

MCK : 383.34 (+0.68%)
AMN : 122.48 (+0.50%)
GKOS : 47.13 (-0.65%)
LNTH : 58.45 (-0.53%)
Alcon (ALC) Q3 Earnings Surpass Estimates, Sales Guidance Cut

Alcon's (ALC) robust innovation pipeline is delivering solid results as evidenced by the strength in its comprehensive portfolio of PCIOLs, including PanOptix and Vivity.

MCK : 383.34 (+0.68%)
ALC : 68.32 (+0.49%)
AMN : 122.48 (+0.50%)
SWAV : 264.27 (+0.08%)
Here's Why You Should Add McKesson (MCK) Stock Right Now

McKesson (MCK) continues to benefit from strategic partnerships and strength in the Distribution Solutions segment.

MCK : 383.34 (+0.68%)
AMN : 122.48 (+0.50%)
HCA : 239.37 (+0.88%)
LNTH : 58.45 (-0.53%)
The Zacks Analyst Blog Highlights Archer-Daniels-Midland, McKesson, Marathon Petroleum, Exxon Mobil and Merck & Co

Archer-Daniels-Midland, McKesson, Marathon Petroleum, Exxon Mobil and Merck & Co are part of the Zacks top Analyst Blog.

XOM : 113.21 (-0.35%)
MRK : 107.50 (+0.64%)
ADM : 97.40 (+0.64%)
MCK : 383.34 (+0.68%)
MPC : 125.20 (-0.32%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

McKesson Corporation is a health care services and information technology company. McKesson operates through two segments: The Distribution Solutions segment distributes branded and generic pharmaceutical drugs along with other healthcare-related products on a global basis worldwide. The segment also...

See More

Key Turning Points

3rd Resistance Point 392.73
2nd Resistance Point 389.88
1st Resistance Point 386.61
Last Price 383.34
1st Support Level 380.49
2nd Support Level 377.64
3rd Support Level 374.37

See More

52-Week High 401.78
Last Price 383.34
Fibonacci 61.8% 330.53
Fibonacci 50% 308.52
Fibonacci 38.2% 286.52
52-Week Low 215.27

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar